Company Description

QTREX Quantum Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel.

It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less.

It also offers HYLA blood sensor, which is designed to perform real-time sampling and analysis of key blood parameter measurements.

The company was formerly known as Inspira Technologies Oxy B.H.N. Ltd. and changed its name to QTREX Quantum Ltd. in May 2026.

QTREX Quantum Ltd. was incorporated in 2018 and is headquartered in Ra'anana, Israel.

QTREX Quantum Ltd.

Country	Israel
Founded	2018
IPO Date	Jul 14, 2021
Industry	Computer Hardware
Sector	Technology
Employees	37
CEO	Dagi Ben-Noon

Contact Details

Address: 2 Ha-Tidhar St. Ra'anana, 4366504 Israel
Phone	972 4 623 0333
Website	q-trex.com

Stock Details

Ticker Symbol	QTEX
Exchange	NASDAQ
Fiscal Year	January - December
Reporting Currency	USD
CIK Code	1837493
ISIN Number	IL0011715781
SIC Code	3841

Key Executives

Name	Position
Dagi Shahar Ben-Noon	Co-Founder, Chief Executive Officer and Director
Yafit Tehila	Chief Financial Officer
Avi Shabtai	Chief Operating Officer and Vice President of Research and Development
Daniella Yeheskely-Hayon M.B.A., Ph.D.	Chief Technology Officer
Sivan Ozeri	Administrative Manager
Adi Shmueli	Director of Marketing
Mike Hershkovitz	Vice President of Global Sales
Yoav Rozanovich	Chief Business Officer

Latest SEC Filings

Date	Type	Title
Jun 11, 2026	6-K	Report of foreign issuer
Jun 9, 2026	6-K	Report of foreign issuer
Jun 4, 2026	F-3	Filing
Jun 1, 2026	6-K	Report of foreign issuer
Jun 1, 2026	6-K	Report of foreign issuer
Jun 1, 2026	144	Filing
Jun 1, 2026	144	Filing
Jun 1, 2026	144	Filing
Jun 1, 2026	144	Filing
May 29, 2026	144	Filing

View All SEC Filings